Hot Posts

6/recent/ticker-posts

Ad Code

Responsive Advertisement

Apply for Osteosarcoma Institute's Grant Program 2024

"Visual representation of research efforts in osteosarcoma, highlighting clinical trials, correlative science, preclinical studies, and high-risk/high-impact research supported by the Osteosarcoma Institute's Grant Program for 2024."


Published Date: September 13, 2024

Application Deadline: October 31, 2024

Grant Categories & Scope

The Osteosarcoma Institute offers grants in the following categories:

  • Clinical Trials: Up to $800,000 over 2-3 years for Phase I/II or Phase II trials aimed at improving event free survival in relapsed/refractory osteosarcoma.
  • Correlative Science: $200,000 – $500,000 over 2 years for studies generating data to improve understanding and treatment of recurrent and metastatic osteosarcoma.
  • Preclinical/Translational: Up to $500,000 for 2 years focusing on identifying biological dependencies in osteosarcoma.
  • High-Risk/High-Impact: $25,000 – $125,000 over 1 year for bold, innovative research with potential high impact on osteosarcoma treatment.

Eligibility Criteria

To be eligible, applicants must meet the following criteria:

  • Funds are granted to nonprofit/charitable institutions or organizations.
  • The grantee organization does not need to be based in the United States.
  • Applicants must hold an MD, PhD, MD/PhD, or equivalent and be faculty members or equivalent at an academic institution.
  • Applicants are not required to be U.S. citizens.
  • Applicants should have a track record of publication and funding productivity.
  • The proposed project must represent a new research direction, not a continuation of ongoing funded research.

Additional Information

Selected grantees will allow OSI to publicize the grant for fundraising purposes, including a five-minute video discussing the research project and related photos.

For more information and to apply, visit the Osteosarcoma Institute's Grant Program 2024.

Post a Comment

0 Comments

Ad Code

Responsive Advertisement